<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Trilink on Bioecon</title><link>https://en.bioecon.ru/companies/trilink/</link><description>Recent content in Trilink on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sat, 11 Jul 2026 14:19:14 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/trilink/index.xml" rel="self" type="application/rss+xml"/><item><title>Prime editing</title><link>https://en.bioecon.ru/technology/prime-editing/</link><pubDate>Fri, 26 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/prime-editing/</guid><description>Search-and-replace genome editing with a Cas9 nickase fused to a reverse transcriptase and an extended pegRNA — writing all 12 base substitutions and small indels without a double-strand break.</description></item><item><title>mRNA platforms &amp; LNP delivery</title><link>https://en.bioecon.ru/technology/mrna-platforms-lnp-delivery/</link><pubDate>Thu, 18 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/mrna-platforms-lnp-delivery/</guid><description>Synthetic mRNA in lipid nanoparticles (60–100 nm) turns the cell into a bioreactor — from a vaccine platform to personalised cancer immunotherapy and in-vivo protein expression.</description></item></channel></rss>